4//SEC Filing
VERTEX PHARMACEUTICALS INC / MA 4
Accession 0001209191-12-031019
$VRTXCIK 0000875320operating
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:26 PM ET
Size
7.5 KB
Accession
0001209191-12-031019
Insider Transaction Report
Form 4
Kelly Lisa
SVP, Human Resources
Transactions
- Sale
Common Stock
2012-05-24$62.74/sh−900$56,466→ 22,355 total - Sale
Common Stock
2012-05-24$63.38/sh−5,106$323,618→ 17,249 total
Holdings
- 1,667(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
- [F2]Open market sales reported on this line occurred at a weighted average price of $62.74 (range $62.25 to $62.99).
- [F3]Ms. Kelly-Croswell undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- [F4]Open market sales reported on this line occurred at a weighted average price of $63.38 (range $63.06 to $63.62).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0000875320
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:26 PM ET
- Size
- 7.5 KB